March 23, 2026

Biosimilar

1768263279 unnamed file.jpg

Delhi HC clears Zydus biosimilar, boosting access to affordable cancer care | India News

contact@dailyupdatesindia.com03 mins

NEW DELHI: In a significant ‘public interest’ move, the Delhi High Court has allowed Zydus Lifesciences to manufacture and sell a biosimilar of Bristol Myers Squibb’s blockbuster cancer therapy, Nivolumab. Priced around 70% less than the patented therapy, the Zydus biosimilar is expected to improve patient access and affordability significantly.A division bench of Justices C…

Read More
1763991871 unnamed file.jpg

Biosimilar push: Dr Reddy’s gets EU nod for denosumab copy; Prolia, Xgeva rivals set for rollout

contact@dailyupdatesindia.com01 mins

Dr Reddy’s Laboratories has secured a major regulatory milestone with the European Commission granting marketing authorisation for AVT03, its biosimilar to denosumab used in osteoporosis treatment. The approval covers all EU member states as well as Iceland, Liechtenstein and Norway under the European Economic Area framework.The company said AVT03 is a biosimilar version of Prolia…

Read More